Last reviewed · How we verify
NCT04410770
Mood Tracker Smartphone App for Management of Emotional Distress After TBI
Phase 2 trial testing Mood tracker ratings in Emotional Distress in 126 participants. Status unknown.
30 April 2022
Quick facts
| Lead sponsor | Memorial Hermann Health System |
|---|---|
| Phase | Phase 2 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 126 |
| Start date | 23 April 2019 |
| Primary completion | 30 April 2022 |
| Estimated completion | 29 September 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Mood tracker ratings
Conditions studied
- Emotional Distress — all drugs for Emotional Distress →
Sponsor
Memorial Hermann Health System
Who can join
Adults 18 to 62, any sex, with Emotional Distress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Traumatic brain injury (TBI) is a common type of injury that affects thousands of people a year. TBI can cause a number of disabilities such as impaired cognition, decreased strength, decreased balance, problems controlling feelings, and difficulty communicating with others. Other problems that persons with TBI can have in the period after hospital discharge are anxiety and depress. These problems are common. At about one year after being injured, 44% of people have anxiety and 40% have depression. By five years after injury, 28% have depression and 17% have anxiety. If we think of emotional distress as having depression, anxiety, or both, at one year, 53% of people with TBI have emotional distress and, at five years, 38% have emotional distress. Many people with TBI are reluctant to seek help for emotional problems and when they do want help, it is hard to find. Many states have a shortage of mental health providers, many injured persons lack insurance that would pay for mental health treatment, and treatment may only be available a long distance from where people live. In an attempt to address this problem, we are conducting a study designed to determine whether a self-management strategy can improve emotional distress or make emotional distress less like to develop. Previous studies have shown that simply keeping track of a problem may improve it. For example, tracking how often one has headaches can result in fewer headaches. Keeping track of one's blood pressure can lead to lower blood pressure. We are conducting this study to see if tracking one's level of emotional distress will result in lower levels of emotional distress. We are asking people with TBI to rate their levels of emotional distress several times a week using a special smart phone app. We will then conduct statistical tests to see if completing these ratings can cause people to have less emotional distress or prevent emotional distress from developing.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Dimensions of participation as predictors of satisfaction with roles and abilities after traumatic brain injury.
Wisinger AM, Juengst SB, Sander AM, Broomfield RR, et al · · 2026 · PMID 40608439 · DOI 10.1037/rep0000627
Verify or expand the search:
- PubMed search for NCT04410770
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Emotional Distress
Currently open trials in the same condition.
- NCT07436845 — Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arte · recruiting
- NCT06713460 — Emotional Intelligence Intervention to Improve Mental Well-Being of Adolescents With Emotional Distress (BEAM) · NA · recruiting
- NCT05712057 — Neurostimulation Versus Therapy for Problems With Emotions · NA · recruiting
- NCT05639465 — Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children · NA · recruiting
Other Memorial Hermann Health System trials
Trials by the same sponsor.
- NCT06801054 — Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dose · Phase 1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04410770 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Memorial Hermann Health System
- Last refreshed: 2 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04410770.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing